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Abstract
Protocadherin-1 (PCDH1) is a novel susceptibility gene for airway hyperresponsiveness, first identified in families exposed to
cigarette smoke and is expressed in bronchial epithelial cells. Here, we asked how mouse Pcdh1 expression is regulated in
lung structural cells in vivo under physiological conditions, and in both short-term cigarette smoke exposure models
characterized by airway inflammation and hyperresponsiveness and chronic cigarette smoke exposure models. Pcdh1 gene-
structure was investigated by Rapid Amplification of cDNA Ends. Pcdh1 mRNA and protein expression was investigated by
qRT-PCR, western blotting using isoform-specific antibodies. We observed 87% conservation of the Pcdh1 nucleotide
sequence, and 96% conservation of the Pcdh1 protein sequence between men and mice. We identified a novel Pcdh1
isoform encoding only the intracellular signalling motifs. Cigarette smoke exposure for 4 consecutive days markedly
reduced Pcdh1 mRNA expression in lung tissue (3 to 4-fold), while neutrophilia and airway hyperresponsiveness was
induced. Moreover, Pcdh1 mRNA expression in lung tissue was reduced already 6 hours after an acute cigarette-smoke
exposure in mice. Chronic exposure to cigarette smoke induced loss of Pcdh1 protein in lung tissue after 2 months, while
Pcdh1 protein levels were no longer reduced after 9 months of cigarette smoke exposure. We conclude that Pcdh1 is highly
homologous to human PCDH1, encodes two transmembrane proteins and one intracellular protein, and is regulated by
cigarette smoke exposure in vivo.
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Introduction
Asthma is a complex disease caused by gene-gene and gene-
environment interactions [1]. Many asthma susceptibility genes
have been identified, several of which are expressed in the airway
epithelium [2]. The airway epithelium in asthma has a disrupted
barrier function [3] and an impaired repair response upon injury
[4,5] that might contribute to airway remodelling. In addition, the
airway epithelium of asthmatics shows an enhanced immune
response towards harmful agents (allergens or viruses) by secreting
increased amounts of pro-inflammatory mediators such as IL-33,
CCL20, GM-CSF or TSLP [6–9]. Polymorphisms in asthma
susceptibility genes expressed by airway epithelial cells, affecting
the level or regulation of their expression [10], might therefore
contribute to both altered barrier function of airway epithelial cells
and to enhanced induction of an immune response upon airway
epithelial injury [11].
Previously, we identified protocadherin-1 (PCDH1) as a novel
susceptibility gene for airway hyperresponsiveness (AHR) in
asthma families [12]. Interestingly, a strong linkage signal of
PCDH1 with asthma and AHR was observed in families exposed
to environmental tobacco smoke (ETS). PCDH1 encodes for two
main isoforms: a 3 exon and a 5 exon isoform that are expressed in
the airway epithelium [12]. In addition a putative third isoform
was identified that lacks exon 1 and part of exon 2 [13]. Both main
isoforms encode a protein containing an extracellular domain with
seven cadherin repeats, a transmembrane domain, and an
intracellular domain containing several Serine and Tyrosine
residues, that have been found to be subject to phosphorylation
[14,15]. The third isoform only contains two extracellular
cadherin repeats and the shared intracellular domain. In addition,
both isoforms 2 and 3 encode an additional intracellular domain
containing three intracellular conserved motifs (CM1–CM3), of
which CM3 is the binding motif for protein phosphatase 1 alpha
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(PP1a) [16,17]. We previously reported complex splicing patterns
of PCDH1 regarding the expression of intracellular conserved
motifs, and observed a marked upregulation of PCDH1 during
mucociliary differentiation of primary bronchial epithelial cells
[13].
In mouse, Pcdh1 mRNA expression was identified in several
adult tissues (brain, kidney, heart, lung and uterus), but highest
expression was observed in lung [18]. During mouse embryogen-
esis, Pcdh1 mRNA expression in lung was restricted to mesen-
chyme and blood vessels, and was not detected in the bronchial
epithelium. Similar to the human situation, two main transcripts
were identified in the mouse, as well as a variant displaying
variation in expression of conserved motifs [16].
As PCDH1 was originally identified as a susceptibility gene for
AHR in families exposed to cigarette smoke and encodes an
adhesion molecule that is expressed in the airway epithelium, we
hypothesize that environmental exposures such as cigarette smoke
may affect PCDH1 levels or function in the airways. Currently,
detailed knowledge about Pcdh1 expression in lung structural cells
and its regulation by environmental exposures in vivo is unknown.
Therefore, we aimed to investigate the expression and regulation
of Pcdh1 under basal conditions in vivo and in both short-term and
chronic cigarette smoke exposure mouse models.
Materials and Methods
Animal Models
BALB/c and A/J mice (6 to 8 weeks, n = 61 for BALB/c and
n=28 for A/J in total) were purchased from Charles River
Laboratories (L’Arbresle-Cedex, France), housed in individually
ventilated cages, kept under specific pathogen-free conditions and
maintained on a 12 h light-dark cycle, with food and water ad
libitum. Experiments were approved by the Institutional Animal
Care and Use Committee of the University of Groningen (The
Netherlands), and carried out following (inter-)national welfare
regulations.
Sub-chronic and acute cigarette smoke (CS) exposure models.
BALB/c mice were exposed to gaseous-phase CS from
Kentucky 3R4F research reference cigarettes (Tobacco Research
Institute, University of Kentucky, Lexington, USA). Each cigarette
was smoked without filter in 5 minutes at a rate of 5 L/hr in a
ratio with 60 L/hr air using whole body exposure. Gaseous-phase
CS was directly distributed inside 6-liter perspex boxes. In this
study we employed two whole-body CS-exposure models:
Sub-chronic CS exposure model: Female mice (n = 8 per group) were
exposed to CS of 1–5 cigarettes for 5 days or filtered air each
morning and afternoon, using a peristaltic pump as described
previously [19]. Mice were sacrificed 2 h after the last CS
exposure. The results were replicated in a second independent
experiment (n = 8 per group) that was performed in the same way,
with the exception that no Bronchial Alveolar Lavage (BAL)-fluid
was isolated. In total 32 mice were used for these two independent
experiments.
Acute CS exposure model: Male mice were exposed to CS of 10
cigarettes (n = 8) in 1.5 h or filtered air (n = 5), and were sacrificed
6 h after the last CS exposure. This experiment was performed
once, with 13 mice in total.
From all mice, BAL-fluid was isolated and the smallest lung lobe
was stored at 280uC for RNA or protein isolation. BAL was
obtained, by lavaging through a tracheal cannula with five 1 ml
aliquots of saline of 37uC. Differential BAL cell counts (3 times 100
cells) were obtained from cytospin preparations stained with Diff-
Quick (Merz & Dade A.G., Dudingen, Switzerland).
Airway responsiveness (AHR) was assessed in a separate group
of sub-chronic CS exposed mice at day 5, by omitting the final
smoke exposure (n = 8 per group, 16 mice in total). AHR was
determined by measuring airway resistance in response to i.v.
administration of increasing doses of methacholine (acetyl-b-
methylcholine chloride, Sigma-Aldrich, St. Louis, MO), using a
computer-controlled small-animal ventilator (Flexivent; SCIREQ,
Montreal, Quebec, Canada) as described previously [20].
Chronic CS exposure model:
Female A/J mice were exposed to cigarette smoke from 2R1
reference cigarettes twice daily (2 cigarettes/session, 10 puffs/
cigarette), 5 days per week by nose-only exposure as described
previously [32]. After 2 or 9 months of cigarette smoke exposure,
mice were sacrificed. The right lung lobe was snap frozen for
further analyses.
RNA purification, Rapid amplification of cDNA ends
(RACE) and quantitative (q)RT-PCR
RNA was isolated from 50–100 mg of mouse lung tissue
homogenized in 1 ml of TriReagent (MRC, Cincinnati, OH).
gDNA traces were removed enzymatically, followed by purifica-
tion using RNeasy Mini Kit (QIAGEN). RNA concentration and
integrity was determined by Nanodrop measurements (ND-1000
spectrophotometer, Isogen Lifesciences, de Meern, Netherlands).
RACE was performed on RNA purified from lung tissue
according to the manufacturer’s instructions (GeneRacer-RLM-
RACE Kit, Invitrogen, Carlsbad, USA), and as described
previously [13] using the primers described in Table 1. RACE
was performed from Pcdh1 exon 1 for 59 transcripts and from exon
3 for 39transcripts. Furthermore, additional 59RACE experiments
from exon 3 were performed in order to identify a homolog of the
putative human isoform 3 [13]. PCR products were TOPO-
cloned and Pcdh1 transcripts were sequenced (StarSEQ, Mainz,
Germany) as described previously [13]. Pcdh1 mRNA and protein
sequences were compared to human PCDH1 using ClustalW
(http://www.ebi.ac.uk/Tools/msa/clustalw2/).
Expression levels of Pcdh1 transcripts were determined by qRT-
PCR as described previously [13], using ABI primer-probe sets. In
brief, two microgram of RNA was reverse transcribed in 20 ml
reaction volume using OmniscriptTM reverse transcriptase (QIA-
GEN Benelux BV, Venlo, the Netherlands). Pcdh1 exon 1–2
(Mm01264041_m1, Applied Biosystems Europe BV, Nieuwekerk
A/D IJssel, the Netherlands), Pcdh1 exon 3–4 and Pcdh1 exon m-
1B (Custom assays, Applied Biosystems, Table 1 for primer
sequences) expression was determined relative to the most stable
combination of four housekeeping genes (HPRT1
(Mm01545399_m1), Pgk1 (Mm01225301_m1), B2m
(Mm00437762_m1), Ipo8 (Mm01255158_m1), Applied Biosys-
tems). Data was analyzed using SDS2.3 software by applying the
DDCt-method (Applied Biosystems User Bulletin 2). As four
house-keeping genes were used, for normalization the best
combination of house-keeping genes was determined by using
the Normfinder applet [21]. We calculated relative expression
levels as follows: First the cycle threshold value (Ct-value) of the
average of the combination of most stable house-keeping genes
was subtracted from the Ct-values of our Pcdh1-assays (formula 1).
Next, we converted the DCt-value to expression level (EL; formula
2), and normalized the expression levels relative to the average of
the control group (formula 3). In formulas: 1). DCtPcdh1=CtPcdh12
CtHKG-average; 2). ELPcdh1=2
2DCtPcdh1; 3). Relative EL=ELPcdh1/
ELPcdh1-control.
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Cloning and overexpression of Pcdh1 isoform 3 in
BEAS2B bronchial epithelial cells
Cloning: The human cDNA sequence corresponding to the
mouse isoform 3 sequence obtained by RACE PCR experiments
was amplified from the isoform 2 plasmid (pCMV-XL6-iso2,
TC109554, Origene, Rockville, USA) with forward primer
CCGCGAATTCATTCTCTTTGGTGTGGTGG and reverse
primer CACTGGAGTGGCAACTTC by using PhusionTM High
Fidelity PCR Kit (F-553S, Finnzymes, Fisher Scientific, Land-
smeer, The Netherlands), followed by subcloning of the PCR
product into the pCMV-XL6 expression vector (Origene, USA).
The resulting pCMV-XL6-Pcdh1-Iso3 plasmids were sequenced
(StarSeq Sequencing, Mainz, Germany).
Overexpression: BEAS2B cells were grown as described previously
[22], seeded into 24-well plates, and transfected at a confluency of
60–80% with 0.5 mg of eGFP (expression control, pEGFP-C1,
Westburg BV, Leusden, The Netherlands), full-length Isoform 2
(pCMV-XL6-Pcdh1-iso2), or Isoform 3 plasmid (pCMV-XL6-
Pcdh1-iso3), using Fugene HD transfection reagent according to
the manufacturer’s procedures (Roche Diagnostics, Almere, the
Netherlands). Cells were harvested 48 h after transfection using
leammli buffer (2x leammli: 4% SDS; 20% glycerol; 10% b-
mercaptoethanol; 0.004% bromphenol blue; 0.125 M Tris HCl;
pH 6.8), boiled for 5 min, and analysed for PCDH1 protein
expression by western blotting using the antibody specific for the
intracellular domain encoded by exon 4 (EP76, Figure 1A) [13].
Detection of Pcdh1 protein expression levels by western
blotting
Protein isolation: Frozen lungs were homogenized in 5 ml/mg lysis
buffer (1% Triton-X 100, 150 mM NaCl, 5 mM MgCl2, 10 mM
HEPES, 1:500 Protease Inhibitor Cocktail (P8340, Sigma-Aldrich,
Zwijndrecht, the Netherlands)) using a tissue homogenator (T10
basic, ULTRA-TURRAX, IKA, Staufen, Germany). Subsequent-
ly lung homogenates were boiled for 10 minutes with 2x laemmlli
buffer and stored at 280uC.
Western blotting: Lung tissue homogenates were separated on
7.5% acrylamide SDS-page gels (Bio-Rad Laboratories BV,
Veenendaal, the Netherlands). Detection of Pcdh1 protein was
performed using antibodies that were designed against isoform-
specific peptide sequences in the intracellular tail of both human
PCDH1 variants as described previously [13] (Figure 2A). These
antibodies showed cross-reactivity with mouse Pcdh1 due to high
homology of the immunizing peptide sequences:
(QPFQLSTPQPLPHPYH, EP78, 86% conserved;
SPSPPEDRNTKTAPV, EP76, 100% conserved) (See Figure 1A
for binding sites of antibodies). Antibodies were affinity column
purified against immunizing peptides (Eurogentec, Liege, Bel-
gium), and were validated by blocking experiments using a pre-
incubation period of 30 min at 37uC with 10x molar excess of
immunizing peptides or H2O.
Pcdh1 bands on western blots were visualized using Goat-anti-
Rabbit-Peroxidase (GARPO, Daco, Heverlee, Belgium) as sec-
ondary antibody, and as tertiary step Rabbit-anti-Goat-Peroxidase
(RAGPO, Dako, Heverelee, Belgium) was used. Next, blots were
incubated with Luminol-reagent, and subsequently analysed using
Fuji Medical X-Ray films (Fuji Photo Film Gmbh, Germany),
followed by densitometric analysis using Quantity One Software
v4.6.2 (Bio-Rad), relative to the b-actin loading control (sc-47778,
Santa-Cruz Biotechnology, Heidelberg, Germany).
Statistical analysis
Differences in mRNA or protein expression levels were
statistically tested by Mann-Whitney tests (GraphPad v4.0, La
Jolla, USA). Experimental outliers were determined by using the
Grubbs analysis (http://www.graphpad.com/quickcalcs/
Grubbs1.cfm). Differences in airway hyperresponsiveness between
smoke- and air-exposed mice were determined by testing for
differences in the area under the curve (AUC) using GraphPad
software.
Results
Pcdh1 expression in the mouse lung
To allow an accurate investigation of Pcdh1 expression
regulation in the mouse lung, we first determined the Pcdh1
gene-structure by RACE experiments. Compared to the published
mouse Pcdh1 gene-structure [16], we detected two novel exons on
the 59 end of Pcdh1 (exon m-1b and m-1c, Figure 1A), two novel
exons on the 39 end (exon 3b and exon 5), as well as major
variation in exon 4, containing the conserved CM2-domain and
PDZ-BS motifs (Figure 1A). Exon 3b is a short 39 basepair exon
encoding a premature stop codon, which is completely conserved
between men and mice (See Table 2 for corresponding Genbank
accession numbers). Remarkably, mouse Pcdh1 exons had high
homology to human exons resulting in a 87% homology at the
nucleotide level (Figure 1A) and a 96% homology on protein level
(Figure S1). Previously we detected an isoform lacking several
extracellular domains in human bronchial epithelial cells [13]. We
therefore performed 59RACE experiments from exon 3 in mouse
Table 1. Pcdh1 RACE and qPCR primer sequences.
Pcdh1 RACE primer Sequence (59-39) Corresponding GeneRacer primer Sequence (59-39)
59RACE 301Rev GAGGTCTCTGTGGTGAAAATGTCT GeneRacer 59 primer CGACTGGAGCACGAGGACACTGA
59RACE 162Rev GTTCCTCTGGCACCTTGTATACTACC GeneRacer 59 nested primer GGACACTGACATGGACTGAAGGAGTA
39RACE FW1 GCCCAGGAGCTGCAGGATCCAT GeneRacer 39 primer GTCGTCAACGATACGCTACGTAACG
39RACE FW2 GAAACACCCTCTAGCAAGTCATCCT GeneRacer 39 nested primer CGCTACGTAACGGCATGACAGTG
59RACE Ex3 Rev3 GCTGTGATGGATCCTGCAGCTCCT GeneRacer 59 primer CGACTGGAGCACGAGGACACTGA
59RACE Ex3 Rev2 ACTGGTGGCCGAGAAGGTGACA GeneRacer 59 nested primer GGACACTGACATGGACTGAAGGAGTA
qPCR assay Forward (59–39) Probe (FAM-NFQ labelled) Reverse (59-39)
M-1B–Ex1 CTCAGCATGCGCAGAAGAAAA ACTGTTCTCCTGATTCTGG CCTCAGAGGCCCCATCCT
Ex2-Ex3 GAGCAGTACTCCGACTACAG CCAGCAAGCAGTTACCTCAC TAGAGGGTGTTTCCGATTCC
Ex = exon; Rev = reverse; FW= Forward.
doi:10.1371/journal.pone.0098197.t001
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Figure 1. Pcdh1 gene-structure and isoforms. (A) Two novel exons were detected at the 59end of PCDH1, and one novel exon on the 39end of
Pcdh1. Mouse Pcdh1 exons share high homology with human PCDH1 exons. Corresponding isoforms (isoforms 1, 2 and putative isoform 3) and their
protein structures are depicted. Only isoform 2 and putative isoform 3 contain evolutionary conserved motifs (CM1–3). Two antibodies were
generated against sequences in the intracellular tail of both isoform 1 (EP78) and isoform 2 (EP76) of Pcdh1. An antibody directed against the
extracellular domains of Pcdh1 (EP209) was generated previously [12]. (B) Western blot of lysates of BEAS2B cells overexpressing the open reading
frame of Pcdh1 isoform 3, using antibody EP76 for detection as indicated (left hand panel) including a pre-incubation with the immunizing peptide
(‘Peptide blocked’) as a control for specificity (right hand panel). Western blots using EP78 and EP209 antibodies for detection are also included as
indicated. cds = coding sequence; UTR=Untranslated region; SP = Signal peptide (amino-acid (aa) 1–57); EC= Extracellular Cadherin domain;
TM= Transmembrane domain; CM=Conserved Motif; PDZ-BS = PDZ-domain Binding Site; S = Serine residue; Y = Tyrosine residue; EP209= Binding
site for antibody directed against the extracellular domain of Pcdh1; EP78 = Binding site for antibody directed against a specific intracellular sequence
of isoform 1, encoded by exon 2; EP76 =Binding site for antibody directed against the intracellular domain present in isoforms 2 and 3 and encoded
by exon 4; FL = full length. Genbank accession numbers of novel transcripts are provided in Table 2.
doi:10.1371/journal.pone.0098197.g001
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lung. Interestingly, we identified an additional transcript starting
from within exon 2, containing a CTG Kozak-sequence (isoform
3, Genbank accession JK707011), and putatively encoding a
protein product with an in-frame translation initiation site at
amino-acid no 870 of the full-length Pcdh1 isoform 2 protein
(Genbank accession NP_115796). Overexpression of the corre-
sponding 59-truncated open reading frame in BEAS2B cells
induced 40- and 50 kD Pcdh1 proteins. Both protein products
were specifically detected by the EP76-antibody as intensity of
these bands clearly diminished after blocking with immunizing
peptide, and were not detected with the EP78 and EP209
antibodies (Figure 1B). These results show that in mouse lung a
third, intracellular Pcdh1 isoform is expressed that does not
contain the extracellular and transmembrane domains, but retains
all intracellular domains also present in Pcdh1 isoform 2
(Figure 1A).
We next investigated basal expression of Pcdh1 mRNA and
protein levels in mouse lung tissue. We observed very low levels of
Pcdh1 using the exon m-1b/exon-1 specific qRT-PCR assay, while
much higher expression levels of Pcdh1 were detected using exon
1–2 and exon 3–4 specific assays (Figure 2A). On western blot of
whole mouse lung homogenate, we observed one specific band of
150 kD and a non-specific band of 140 kD, using an antibody
generated against the intracellular tail of the PCDH1 isoform 1
(EP78, Figure 2B). In contrast, we observed a 50 kD and 170 kD
bands using a specific antibody generated against the intracellular
tail present in PCDH1 isoforms 2 and 3 (EP76, Figure 2B).
Short term smoke exposure down regulates Pcdh1
expression levels
Given the initial linkage of PCDH1 to AHR and asthma in
cigarette smoke exposed families defined by a significant smoking
history of the asthma proband of more than 5 packyears [12], we
investigated whether Pcdh1 expression was regulated in a sub-
chronic (5 days) smoke exposure model (Figure 3A). This model
induced a neutrophillic influx into the airways (Figure 3A), a
feature of sub-chronic smoke exposure models [19,23], as well as a
trend towards AHR to methacholine (p = 0.056, Figure 3A).
In CS-exposed mice, we observed significantly lower expression
of Pcdh1 transcripts encoding exon 1–2 (3.9 fold, p = 0.0003) and
exon 3–4 (3.3-fold, p= 0.0003) in total lung (Figure 3B, left panel).
Next, we investigated whether this was reflected at the protein
level in total mouse lung homogenate. No differences in Pcdh1
isoform 1 protein levels were found, but a trend towards lower
levels of the 170 kd Pcdh1 isoform 2 protein band (p = 0.052,
Figure 3C and 3D, left panels) was observed by western blot after 5
days of smoke exposure.
In order to evaluate the reproducibility of our results, we
performed an independent replication of the sub-chronic smoke
exposure model. One RNA sample of the air-exposed group was
excluded due to insufficient RNA quality. We detected one outlier
in the smoke exposed group, both for exon 1–2 and exon 3–4
expression and tested for differences between smoke and air
exposed mice with and without outliers. We observed a trend
towards lower Pcdh1 exon 1–2 expression (p = 0.16/p=0.39;
Table 2. Genbank accession numbers of novel Pcdh1 transcripts.
RACE reaction Protocadherin-1 Sequence GenBank Accession number
Mm 59RACE exon 1 Exon m-1b - 1 JK707005
Mm 59RACE exon 1 Exon m-1c - 1 JK707006
Mm 59RACE exon 1 Exon m-1c - 1 (short exon) JK707007
Mm 39RACE exon 3 Exon 3-3b-4 JK707008
Mm 39RACE exon 3 Exon 4 including gap JK707009
Mm 39RACE exon 3 Exon 4-5 JK707010
Mm 59RACE exon 3 Exon 2-3 (Isoform 3) JK707011
Hs 39RACE exon 3 Exon 3-3b-4–5 JK707004
Mm=Mus musculus; Hs = Homo sapiens.
doi:10.1371/journal.pone.0098197.t002
Figure 2. Basal Pcdh1 mRNA and protein expression in lung. (A) mRNA expression levels of exon m-1b, exon 1–2 and exon 3–4 containing
transcripts in naive mouse lung of four mice. (B) Western blot of mouse lung homogenate using the antibody directed against the intracellular
domain of Pcdh1 isoform 1 (EP78), and the antibody directed against the intracellular domain encoded by exon 4 of Pcdh1 (isoform 2, EP76) (see
arrows for the Pcdh1 specific bands), with b-actin as loading control. m1= lung homogenate of mouse number 1; FL = full length.
doi:10.1371/journal.pone.0098197.g002
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Figure 3. Pcdh1 mRNA expression levels decrease after sub chronic smoke exposure. (A) In the sub chronic smoke exposure model, mice
were exposed to 1 and 3 cigarettes or air at day 1, followed by 5 cigarettes at day 2–5 or air. 2 h after the last cigarette both smoke and air exposed
mice were sacrificed. Neutrophils in the bronchoalveolar lavage fluid, and airway hyperresponsiveness to methacholine were determined. Error bars
show Standard Deviation. Two independent experiments are shown individually. (B) Pcdh1 exon 1–2 and 3–4 transcript levels were determined in
lungs of air exposed (open symbols) and smoke exposed (closed symbols) mice. (C) Pcdh1 protein levels were determined by western blot of lung
homogenate of air (control) and smoke exposed mice. Pcdh1 isoform 1 (arrow indicates the specific band; EP78-antibody), full-length isoform 2
Expression and Regulation of Pcdh1 in Mouse Lung
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without/with outliers) and clearly replicated the decrease of Pcdh1
exon 3–4 expression after smoke exposure (p = 0.007/p= 0.04;
without/with outliers; results without outliers are shown in
Figure 3B, right panel). When we combined the two experiments
we observed very significantly reduced expression of Pcdh1 exon 1–
2 (p = 0.0015) and Pcdh1 exon 3–4 (p,0.0001) mRNA. We were
not able to replicate the trend towards lower isoform 2 protein
expression, as we did not detect a difference in protein levels of all
Pcdh1 isoforms in the replication experiment (Figure 3C and 3D,
right panels).
To test whether the down regulation of Pcdh1 mRNA expression
levels was a direct effect of CS-exposure, we also analyzed Pcdh1
expression shortly after an acute CS-exposure, in which no
significant neutrophilic influx was observed (Figure 4A). Remark-
ably, already 6 hours after CS-exposure, a 2-fold (p = 0.006)
decrease in exon 1–2 expression levels and a 1.6-fold (p = 0.03)
decrease in exon 3–4 expression levels was observed (Figure 4B),
suggesting that Pcdh1 expression indeed is directly regulated by
CS-exposure. This difference was not paralleled by a reduced lung
Pcdh1 protein expression at this time-point (Figure 4C and 4D).
Chronic smoke exposure down regulates Pcdh1 protein
levels after 2 months
Next, we aimed to test whether the observed effects of CS
exposure on Pcdh1 isoform 2 expression levels in lung tissue were
retained after chronic smoke exposure. To this end, we analyzed
lung tissue of A/J mice exposed for 5 days a week to cigarette
smoke for 2 months and 9 months, compared to air-treated control
mice (Figure 5). Here, we find that both the 150 kd full-length
(p = 0.011) and the 50 kd band (p = 0.049) of Pcdh1 isoform 2 were
significantly reduced in lung tissue after 2 months of CS exposure
compared to control treatments (Figure 5A, B) while after 9
months of CS exposure, no differences in Pcdh1 protein levels in
lung tissue could be detected compared to air control-treatment
(Figure 5A, C).
Discussion
In this study, we provide a full characterization of the expression
pattern of Pcdh1, the murine homologue of PCDH1, a novel
AHR susceptibility gene identified in families exposed to
environmental cigarette smoke. We assessed Pcdh1 expression in
the mouse lung and its regulation in vivo in both short-term and
chronic CS exposure models. Here, we show that the mouse and
human genes for Protocadherin-1 are highly homologous, both at the
nucleotide and at the amino-acid level, validating the mouse as a
relevant model to study Pcdh1 function. In addition to the two
annotated isoforms of Pcdh1 that differ in their cytoplasmic
signalling domains, we observed expression of a novel Pcdh1
isoform, characterized by the lack of extracellular and transmem-
brane domains, whilst containing all of the intracellular domains
also present in isoform 2. Exposure of mice to cigarette smoke
induced a rapid and strong reduction of Pcdh1 mRNA expression
in lung tissue within 6 hours. Moreover, exposure of mice to CS
for 5 days induced a strongly reduced level of Pcdh1 mRNA
expression in the lung, which in one out of two experiments
performed was also observed at the protein level for Pcdh1 isoform
2. The reduced protein levels of Pcdh1 isoform2 are retained in
chronic CS exposure models after 2 months, but are no longer
observed after 9 months of CS exposure.
When comparing the gene-structure of Pcdh1 to human PCDH1
[13], we observed a striking homology between the two; with 87%
at the nucleotide level and 96% at the amino-acid level (Figure 1A,
Figure S1). Moreover, the low expression levels of alternative
59exons (exon m-1b), the gap in exon 4 [13,16] resulting in
deletion of conserved CM2-domains, and the novel exon 5 are also
conserved between man and mouse [13]. In addition to the high
level of conservation we obtained evidence for a third Pcdh1
isoform that initiates transcription from within exon 2 and
contains a CTG start-codon [24] within a conserved KOZAK
sequence (Figure 1A). Overexpression of this isoform induced
expression of 40-and 50 kD PCDH1 proteins that were only
detected by the antibody generated against the intracellular
domain encoded by exon 4 also present in isoform 2 (EP76-
antibody). These results suggest that in mouse lung a third Pcdh1
protein isoform is expressed containing intracellular domains, but
not extracellular cadherin repeats. Its function may involve cell
signalling rather than cell adhesion, which will be subject of future
investigations. We were not able to identify the exact cell-types
that express this novel isoform, using the combination of
approaches employed by us. The 16HBE bronchial epithelial
cell-line however, was shown to display a 50 kd band on Western
blot that could correspond to this novel isoform [13], but it might
also represent a posttranslational modification of the full-length
isoform 2 protein as has been observed for other protocadherins
[25].
PCDH1 was first identified as a susceptibility gene for AHR in
families exposed to environmental tobacco smoke [12]. The
human chromosomal region 5q31–33, containing PCDH1, was
previously linked to AHR and asthma in 95 ETS exposed families.
In this study, ETS exposure was defined by a significant smoking
history of the proband of the asthma family. Associations of
PCDH1 gene-variants with AHR were further investigated in four
populations of children exposed to ETS in utero or in early life.
PCDH1 gene-variant rs3822357 was associated with AHR in ETS
exposed children in one population only [12]. The effect of genetic
variation of the AHR susceptibility gene PCDH1 on its expression
and the putative interaction with cigarette smoke exposure as an
environmental factor is currently unknown.
In the current study, we analyzed the regulation of Pcdh1
expression in experimental mouse models of cigarette smoke
exposure. We observed that CS-exposure strongly reduced Pcdh1
mRNA expression levels, as determined in whole lung homoge-
nate. Since loss of Pcdh1 expression is already observed as early as
6 hours after CS-exposure, Pcdh1 expression might in fact be
regulated directly by CS-exposure as this time-point precedes
significant influx of inflammatory cells in the airways. Importantly,
we replicated the reduction of Pcdh1 mRNA expression levels after
4 days CS exposure, and we were able to detect down-regulation
of Pcdh1 isoform 2 protein levels in lung tissue in this sub-chronic
CS exposure model in one out of two experiments. Importantly,
the observed down-regulation of Pcdh1 isoform 2 protein levels
was retained after 2 months of chronic CS exposure.
Remarkably, in some cases we detect altered expression levels of
Pcdh1 mRNA in absence of altered Pcdh1 protein levels. This
apparent lack of consistent results between mRNA and protein
data for the effect of CS exposure on Pcdh1 expression levels in
lung tissue might be the result of differences in sensitivity between
the qRT-PCR assay used to detect mRNA levels and the western
blot assay used to detect protein levels. Alternatively, posttrans-
(EP76-antibody) and 50 kD (EP76-antibody) levels are shown, with b-actin as loading control. (D) Densitometric quantification of Pcdh1 expression
levels of full-length isoform 1 and 2, and the 50 kD fragment, relative to b-actin. Cig = cigarette; {= time-point at which mice are sacrificed.
doi:10.1371/journal.pone.0098197.g003
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lational modifications of the Pcdh1 protein might affect protein
stability, resulting in a half-life that significantly exceeds that of the
mRNA, indicating that changes in mRNA levels might only
translate into altered protein levels at a relatively late time-point.
All-in-all, the fact that CS exposure reproducibly induces loss of
Pcdh1 expression in all three short-term exposure models and in
the 2 months chronic CS exposure model presented here does
indicate that CS exposure is a relevant environmental factor acting
on Pcdh1 expression levels. These data are very relevant to the
interpretation of the original identification of PCDH1 as an AHR
gene in families exposed to environmental cigarette smoke [12].
Given our results, it is of interest to test whether in human lung
tissue, too, PCDH1 expression levels are affected by CS exposure,
and whether this is a function of the PCDH1 polymorphisms
identified in the original study. Moreover, studies addressing a
putative role for PCDH1 gene polymorphisms in AHR in COPD
patients might also be of considerable interest.
Remarkably, the differences in Pcdh1 isoform 2 protein levels in
lung tissue between smoke- and air-exposed mice were no longer
found after 9 months of CS exposure. Comparing the relative
levels of Pcdh1 isoform 2 protein between the two time-points of
the chronic CS exposure models indicates that this might be due to
a loss of Pcdh1 protein expression over time in the air-control
treated lungs, rather than a restoration of Pcdh1 protein levels in
lungs of CS exposed mice (Figure 5B, C). Further research will
need to disentangle whether progressive loss of Pcdh1 in occurring
in aging lungs or whether any CS-induced regulation of Pcdh1
protein levels is lost at this late time-point.
Mice sub chronically exposed to cigarette smoke showed a trend
towards hyperresponsiveness to methacholine in our experiments,
an effect that was also observed in other studies in smoke exposed
Figure 4. Pcdh1 mRNA expression levels decrease after acute smoke exposure. (A) In the acute smoke exposure model, mice were exposed
to 10 cigarettes, with a 20 min rest period in between two sessions of 5 cigarettes, or to air as a control. Low numbers of neutrophils were observed
in the lung, 6 h the last exposure. (B) Pcdh1 exon 1–2 and 3–4 mRNA expression levels were determined in the cigarette smoke exposed group
(closed symbols) and compared to the air-exposed group (open symbols). (C) Western blot of Pcdh1 isoform 1 (iso 1, EP78-antibody, specific band
indicated with an arrow), isoform 2 (iso 2, EP76-antibody) and the 50 kD fragment (EP76-antibody) in lung homogenate of mice exposed to cigarette
smoke (smoke) or air (control). (D) Densitometric quantification of Pcdh1 expression levels of full-length isoform 1 and 2, and the 50 kD fragment,
relative to b-actin. Cig = cigarette; {= time-point at which mice are sacrificed; CS = cigarette smoke.
doi:10.1371/journal.pone.0098197.g004
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mice [26] and guinea pigs [27]. While PCDH1 was identified as a
susceptibility gene for AHR originally, our data are merely
associative: reduced Pcdh1 expression levels are associated with a
trend towards AHR to methacholine, but no role for Pcdh1 in the
regulation of AHR can be inferred from these data. Nevertheless,
it will be of interest to test in future mechanistic experiments
whether Pcdh1 protein has a direct protein-protein interaction
with other epithelial proteins involved in the regulation of AHR,
or whether loss of Pcdh1 induces a transcriptional response that
induces an increased responsiveness to methacholine inhalation,
for instance through decreased epithelial barrier function. CS is
known to impair the epithelial barrier function, and thereby
induces permeability of airway epithelium, as evidenced by a
decrease in electrical [28] or trans-epithelial [3] resistance.
Epithelial cells are interconnected by tight-junctions (TJ) and
adherens junctions (AJ). CS exposure has been observed to
delocalize the TJ adaptor molecule ZO-1 [29], and down-
regulates several AJ adhesion molecules, including E-cadherin
Figure 5. Pcdh1 protein levels are reduced after 2 months of cigarette smoke exposure. (A) Western blot of Pcdh1 isoform 2 (iso 2, EP76-
antibody) and the 50 kD fragment (EP76-antibody) in lung homogenate of mice exposed to cigarette smoke (smoke) or air (control) for 2 months (left
panel) or 9 months (right panel). (B) Densitometric quantification of Pcdh1 protein levels of full-length 2 and the 50 kD fragment, relative to Histone
H3, after 2 months of CS exposure. (C) Densitometric quantification of Pcdh1 protein levels of full-length 2 and the 50 kD fragment, relative to
Histone H3, after 9 months of CS exposure. Cig = cigarette; {= time-point at which mice are sacrificed; CS = cigarette smoke.
doi:10.1371/journal.pone.0098197.g005
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[30]. The resulting loss of TJ- and AJ stability may subsequently
lead to loss of barrier function of the epithelium. As PCDH1 was
previously reported to have a role in cell-cell adhesion [31], we
hypothesize that CS-induced decrease in Pcdh1 levels might
contribute to the reduced epithelial barrier function after CS
exposure. Since we only provide data on the association of reduced
Pcdh1 expression levels after CS exposure, future mechanistic
studies in for instance Pcdh1 knock-out mice will need to address
whether Pcdh1 has any functional role in the CS-induced response
by the airway epithelium, including loss of epithelial barrier
function.
In conclusion, our data show that Pcdh1 is strongly
conserved between mouse and man. Furthermore, our data
are the first to show that Pcdh1 mRNA expression is strongly
regulated by CS-exposure, both in acute and chronic exposure
models. Future studies on the function of Protocadherin-1,
using novel knockout and/or transgenic approaches, and its
interaction with environmental factors such as CS exposure are
required to provide novel insights into the origins of airway
hyperresponsiveness.
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